This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Asia-Pacific

  1. "A new formulation entering clinical trials...could change how the world fights the pandemic," says Times article.
    Published: April 2021
    Type: Article
  2. India is an emerging economy with a population of more than 1.3 billion people. Over the past several decades the country has experienced rapid development and there has been a marked shift in its disease pattern. Given the rise in the noncommunicable disease (NCD) burden in India, PATH and Access Accelerated undertook an NCD landscaping study to identify key stakeholders as well as barriers and facilitators in the provision of NCD care. PATH developed priority areas of investment based on expert interviews, local prevalence data, and a review of policies and related literature exposing barriers and facilitators to access to quality NCD care.
    Published: March 2021
    Type: Resource Page
  3. Medical devices play an essential role in the prevention, diagnosis, and treatment of maternal, neonatal, and child health (MNCH) in low- and middle-income countries. However, medical devices have unique characteristics that make them difficult to manage effectively, particularly in low-resource settings.As countries experience rising life expectancy and a shift toward noncommunicable disease burden, demand is growing rapidly for device-intensive services like life support and chronic disease management. There is also an expectation that this growing need will be met with domestic rather than donor resources as countries move up in income status. Strengthening access to medical devices is therefore a critical area for health system investment.This fact sheet offers an overview of the Market Dynamics for MNCH Medical Devices project (MD4MD), which aims to diagnose key barriers that impede access to MNCH medical devices in low- and middle-income countries and prioritize potential solutions to address these barriers.
    Published: March 2021
    Type: Resource Page
  4. Viral hepatitis affects 325 million people worldwide and claims 1.4 million lives per year, despite a vaccine and effective treatments for hepatitis B (HBV) and a cure for hepatitis C (HCV). In Vietnam, viral hepatitis is the third leading cause of death, with 8 million new infections annually from HBV and HCV combined. HepLINK, a new PATH initiative in partnership with The Hepatitis Fund (EndHep2030), demonstrates a model of decentralized and integrated viral hepatitis service delivery in support of Vietnam's goal to eliminate viral hepatitis by 2030. This fact sheet provides an overview of the project and its intended outcomes.
    Published: March 2021
    Type: Resource Page
  5. Clinical decision support algorithms (CDSAs) are digitized tools that combine an individual’s health information with the health worker’s knowledge and clinical protocols to assist in making diagnosis and treatment decisions. They analyze patient data, providing prompts and reminders that help health care workers deliver a range of services within a continuum of care.Despite several initiatives underway around the use of these digital tools in low-resource settings, there remains a lack of awareness of their impact and cost-effectiveness at the national level, as well as a growing need to streamline how health data is collected and used for decision-making. Though more research is needed, initial evidence suggests that CDSAs can reduce barriers to quality of care and, ultimately, health disparities, leading to greater health impact.This fact sheet summarizes key considerations that countries, implementing partners, and donors should keep in mind when planning for CDSA implementation. It also describes the work PATH, as part of its Tools for Integrated Management of Childhood Illness initiative, is leading to adapt CDSAs for country context and incorporate them into health systems to enable better and more targeted patient care.
    Published: February 2021
    Type: Resource Page
  6. PATH is working with state governments in India to improve access to COVID-19 testing by building a cost effective, sustainable, and scalable model for testing strategy and capacity.
    Published: February 2021
    Type: Resource Page
  7. During the COVID-19 pandemic, governments around the world have rapidly introduced policies to mitigate service disruptions to RMNCAH,N care using innovative adaptations such as telehealth or task shifting. As part of our ongoing COVID-19 Essential Health Services Policy Tracker project supported by the Bill & Melinda Gates Foundation, PATH developed a set of briefs that explore in detail the service delivery adaptations outlined in pandemic-era government policies in five countries (Burkina Faso, Ethiopia, India, Nigeria, and Pakistan) to equip country leaders, donors, and advocates with tactics for maintaining essential health services through the pandemic and beyond.(French translation available for brief on Burkina Faso)
    Published: February 2021
    Type: Resource Page
  8. This capability statement highlights PATH’s efforts to strengthen immunization supply chains in India and Nepal. Our work has centered on the development, introduction, and scale-up of technology and system innovations that increase the efficiency and effectiveness of the region's public health programs.
    Published: January 2021
    Type: Resource Page
  9. PATH is a leader in adapting health innovations with and for women across systems, populations, and geographies. This brief outlines PATH's vision, approach, and areas of expertise in Sexual and Reproductive Health.
    Published: January 2021
    Type: Resource Page
  10. Complementing national COVID-19 surveillance efforts in countries with limited diagnostic capacity to test and trace with expanded data from the environmental surveillance of sewage
    Published: January 2021
    Type: Press Release
Load more